Information on 
Informationen zu 
Informaciones sobre
A propos du
Informazioni suPress Room
| Date | Announcement | |
|---|---|---|
| 4 March 2010 | SpePharm announces the acquisition of Savene from TopoTarget, |
|
| 20 April 2009 | SpePharm announces the European launches of two new products: MuGard® and Xerotin® SpePharm today announced the European introduction of two new products; MuGard® & Xerotin®, aimed at relieving some of the most debilitating side effects experienced by cancer patients. |
|
| 14 April 2009 | SpePharm announces a claim in excess of €35 M against BioAlliance Pharma for breaking up their Joint-Venture SpeBio SpePharm Holding BV announces it intends to file a claim for financial damages and losses of not less than 35 Million Euros against BioAlliance Pharma SA, a French company listed on Paris Euronext. |
|
| 3 March 2009 | SpePharm Holding BV Initiates Legal Actions Against BioAlliance Pharma for Breaking Up Joint-Venture SpeBio SpePharm Holding BV announces today that on February 11th 2009 the Company had initiated a summary proceeding before Dutch courts against BioAlliance Pharma of France. |
|
| 8 September 2008 | SpePharm has selected Alloga as its European logistics partner In line with its aim to establish itself as a pan-European specialty pharma company focused on the registration, marketing and sales of innovative products for hospital markets, SpePharm has selected Alloga as its exclusive European partner to supply logistic, distribution and support services. |
|
| 21 August 2008 | TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare enter into €26 Million Financing of SpePharm Paul Capital Healthcare and SpePharm Holding, B.V., the pan-European specialty pharmaceutical company, today announced that they have entered into a €10 million revenue interest acquisition financing agreement to fund SpePharm’s acquisition of Dantrium ®... |
|
| 20 August 2008 | JHP Pharmaceuticals and SpePharm complete purchase of Dantrium JHP Pharmaceuticals, LLC and SpePharm Holding, BV announced today the successful closing of an asset purchase agreement... |
|
| 4 June 2008 | SpePharm announces the granting of national marketing authorizations for Loramyc in Europe and first launch in the UK. SpePharm Holding B.V., the specialty pharmaceutical company today announced the granting of national approvals of Loramyc in the UK, Denmark, Germany, Belgium, The Netherlands, Luxembourg, Finland and Sweden.... |
|
| 16 February 2008 | SpePharm announces marketing authorizations of Loramyc in the UK, Denmark and Belgium SpePharm Holding, B.V., the pan-European specialty pharmaceutical company, announces the marketing authorizations of Loramyc in the United-Kingdom, in Denmark and in Belgium. |
|
| 4 February 2008 | SpePharm is developing its pan-European organization SpePharm Holding, B.V. announces the development of its European organization with the launch of four subsidiaries covering the main European markets. |
|
| 11 December 2007 | SpePharm appoints Dr. Karl-Gerhard Seifert Chairman of its Supervisory Board SpePharm Holding, B.V. has appointed, effective December 2007, Dr. Karl-Gerhard Seifert Chairman of its Supervisory Board |
|
| 27 August 2007 | Access and SpePharm Announce Licensing of MuGard™ for Europe SpePharm Will Market MuGard in Europe for the Treatment of Oral Mucositis |
|
| 7 June 2007 | SpePharm establishes new subsidiary, SpeBio, to commercialise Loramyc® in Europe SpeBio will market Loramyc® in Europe for the treatment of oropharyngeal candidiasis (OPC) |
|
| 31 May 2007 | SpePharm and Valera Inc mutually terminate agreements SpePharm BV and Valera Pharmaceuticals Inc terminate European license and distribution agreement on Vantas® and Supprelin® |
|
| 7 March 2007 | SpePharm sets up European Joint Venture with BioAlliance Pharma to sell Loramyc® SpePharm will market Loramyc® in Europe for the treatment of oropharyngeal candidiasis (OPC) |
|
| 1 December 2006 | SpePharm opens operational subsidiary in France SpePharm Holding, B.V. today announced the opening of SpePharm SAS France, a wholly-owned subsidiary located in Paris. |
|
| 1 October 2006 | SpePharm appoints Supervisory Board SpePharm Holding, B.V. today announced the appointment of an international Supervisory Board. This follows the launch of SpePharm last month. |
|
| 14 September 2006 | SpePharm, a new specialty pharma company, launched in Amsterdam SpePharm Holding, B.V., a specialty pharmaceutical company dedicated to the sales and marketing of innovative hospital and specialists products throughout Europe, was officially launched today. |
|